McLoughlin, H. S., Moore, L. R., Chopra, R., Komlo, R., McKenzie, M., Blumenstein, K. G., . . . Paulson, H. L. (2018). Oligonucleotide therapy mitigates disease in Spinocerebellar Ataxia Type 3 mice. Ann Neurol.
Citação norma ChicagoMcLoughlin, Hayley S., et al. "Oligonucleotide Therapy Mitigates Disease in Spinocerebellar Ataxia Type 3 Mice." Ann Neurol 2018.
Deismireacht MLAMcLoughlin, Hayley S., et al. "Oligonucleotide Therapy Mitigates Disease in Spinocerebellar Ataxia Type 3 Mice." Ann Neurol 2018.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.